(Q40127306)

17 September 2017

1 reference

title

Inhibitors of angiotensin-converting enzyme (English)

1 reference

17 September 2017

Cushman DW

1

1 reference

17 September 2017

Ondetti MA

series ordinal

2

1 reference

17 September 2017

publication date

1 January 1980

1 reference

Progress in medicinal chemistry

17 September 2017

published in

1 reference

17 September 2017

volume

17

1 reference

17 September 2017

page(s)

41-104

1 reference

Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Agents which block the action of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The biochemistry of the renin-angiotensin system and its role in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Renin-angiotensin system: biochemistry and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Conversion of angiotensin I to angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The other angiotensins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin I-converting enzyme of the kidney cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Biological and biochemical properties of angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin blockade: its clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-converting enzyme from rabbit pulmonary particles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin I-converting enzyme from guinea pig lung and serum. A comparison of some kinetic and inhibition properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin I converting enzyme from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Renal Angiotensin I-Converting Enzyme as a Mixture of Sialo- and Asialo-enzyme, and a Rapid Purification Method

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Properties of three different forms of angiotensin I-converting enzyme from human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Characteristics and Significance of Prodromes of Coronary Care Unit Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin converting enzyme: method of assay and partial purification

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin I converting enzyme of calf lung. Method of assay and partial purification

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Carboxycathepsin--a key regulatory component of two physiological systems involved in regulation of blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Purification and properties of angiotensin-converting enzyme from hog lung

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Human plasma converting enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-converting enzyme from porcine plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-converting enzyme from guinea pig and hog lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Purification of angiotensin I-converting enzyme from human lung

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Solubilization of angiotensin I-Converting enzyme from rabbit lung using trypsin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Subcellular localization and partial purification of a chloride dependent angiotensin-I converting enzyme from rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Substrate specificity of hog plasma angiotensin-converting enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Substrate binding properties of converting enzyme using a series of p-nitrophenylalanyl derivatives of angiotensin I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Formation of angiotensin III by angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

In vivo and in vitro conversion of des-1-Asp angiotensin I to angiotensin III

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Role of converting enzyme in the responses of rabbit atria, aortas, and adrenal zona glomerulosa to [des-Asp1]angiotensin I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Synthesis and evaluation of [des-Asp1]angiotensin I as a precursor for [des-Asp1]angiotensin II (angiotensin III)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The preparation and function of the hypertensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Hydrolysis of bradykinin by angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

studies of plasma bradykininases using radiolabelled substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The bradykininase activities of extracts of dog lung

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Cleavage of active peptides by a lung enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Slow conduction and reentry in the ventricular conducting system. II. Single and sustained circus movement in networks of canine and bovine Purkinje fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

A fluorogenic substrate for angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Studies on the angiotensin converting enzyme with different substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Distribution and properties of angiotensin converting enzyme of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Kinetic properties of pulmonary angiotensin-converting enzyme. Hydrolysis of hippurylglycylglycine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Pharmacology of antagonists of angiotensin I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Synthesis and pharmacology of a prohormone angiotensin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibitors of the pulmonary angiotensin I-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The existence of two forms of hypertensin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Experiment to detect Pulsed γ-Rays from the Crab Nebula

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effects of Diphenylhydantoin on Excitability and Automaticity in the Canine Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Peptide inhibitors of converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Some enzymatic properties of peptidyl dipeptide hydrolase (angiotensin I-converting enzyme).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Functional residues at the active site of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Equine angiotensin converting enzyme: a zinc metalloenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Potentiation of the cerebral vascular action of bradykinin by the 'bradykinin potentiating factor' (BPF) in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Subcellular distribution and properties of the bradykinin inactivation system in rabbit brain homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Antinociceptive action of intraventricular bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Fate of angiotensin I in the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Metabolism of the angiotensins in isolated perfused tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin I converting enzyme by venom peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The inactivation of bradykinin in the pulmonary circulation of isolated lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Bradykinin-potentiating peptides from the venom ofAgkistrodon halys blomhqffii

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Structure of bradykinin-potentiating peptide containing tryptophan from the venom ofAgkistrodon halys blomhoffii

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Structure of potentiator A, one of the five bradykinin potentiating peptides from the venom of Agkistrodon halys blomhoffii

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Application of mass spectrometry to sequence analysis of pyroglutamyl peptides from snake venoms: contribution to the confirmation of the amino acid sequence of bradykinin-potentiating peptides B, C and E isolated from the venom of Agkistrodon halys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin I converting enzyme and kininase in rabbit plasma by bradykinin potentiating peptide B (Pyr-Gly-Leu-Pro-Arg-Pro-Lys-Ile-Pro-Pro)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Peptide inhibitors of pulmonary angiotensin I converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The renin--angiotensin system: inhibition of converting enzyme in isolated tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of blockade of angiotensin-I converting enzyme on the blood pressure of renal hypertensive rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin I-initiated hemodynamic changes in anesthetized dogs by a synthetic nonapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Bradykinin potentiating and sensitizing activities of new synthetic analogs of snake venom peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Synthesis and properties of new bradykinin potentiating peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Soluble dextran complexes of Kallikrein, Bradykinin and enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The bradykinin potentiating activity of two pentapeptides on various isolated smooth muscle preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Structure-activity relationships of bradykinin potentiating peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Intrarenal conversion of angiotensin I to angiotensin II in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Alkylating analogs of peptide hormones. 1. Synthesis and properties of p-(N,N-)-bis(2-chloroethyl)amino)phenylbutyryl derivatives of bradykinin and bradykinin potentiating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The mechanism of action of two bradykinin-potentiating peptides on isolated smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inactivation of bradykinin the plumonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Bradykinin analogs containing .beta.-homoamino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Conversion of angiotensin I to angiotensin II in the canine mesenteric circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effects of angiotensin I and antiotensin II on canine hepatic vascular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Substance P degradation by rat brain peptidases: inhibition by SQ 20881.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Design of new antihypertensive drugs: Potent and specific inhibitors of angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

In vitro study on the effects of bradykinin potentiating factor and angiotensin II analogue on degradation and conversion of angiotensin I and II in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Des-Asp1-angiotensin I: a metabolite of angiotensin I in the perfused feline adrenal

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of converting enzyme of the renin-angiotensin system in kidneys and hindlegs of dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Greene LL, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of central pressor effects of agiotensin I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Carboxypeptidase A: a protein and an enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

New sulfhydryl compounds with potent antihypertensive activities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of brain angiotensin-1 converting enzyme by Bothrops jararaca nonapeptide (SQ 20881) and a prolyl analog (SQ 14225)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Design of potent and specific inhibitors of carboxypeptidases A and B

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

A specific orally active inhibitor of angiotensin-converting enzyme in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Autonomic neural influences on the dysrhythmias resulting from myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Concentrations of angiotensin-converting enzyme in tissues of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Differential distribution of angiotensin converting enzyme in the anterior and posterior lobe of the rat pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-converting enzyme in human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-converting enzyme: Presence of high activity in choroid plexus of mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Elevation of Serum Angiotensin-Converting Enzyme in Gaucher's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Peptidyl dipeptidase in rabbit brain microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Escherichia coli mutants defective in dipeptidyl carboxypeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Evidence for myocardial conversion of angiotensin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Conversion of angiotensin I into angiotensin II in the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effects of angiotensin I and angiotensin II on hindlimb and coronary vascular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Role of extrapulmonary conversion in mediating the systemic pressor activity of angiotensin I.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Response to angiotensins I and II and to AI-converting-enzyme inhibitor in a shark

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Role of Converting Enzyme in the Cardiovascular and Adrenal Cortical Responses to (des-Asp)-Angiotensin I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Modification of responses to sympathetic nerve stimulation by the renin-angiotensin system in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Characterization of central angiotensin II receptors involved in the elicitation of drinking in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin I as a dipsogen: efficacy in brain independent of conversion to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Drinking induced by injections of angiotensin into forebrain and mid-brain sites of the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of a converting enzyme inhibitor (SQ 20,881) on angiotensin-induced drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin and thirst: studies with a converting enzyme inhibitor and a receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of renin‐angiotensin system on sodium intake

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The Renin-Angiotensin System and Thirst: A Reevaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Renin-angiotensin role in thirst: paradoxical enhancement of drinking by angiotensin converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of renin secretion in the isolated rat kidney by angiotensin I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of a renal prostaglandin on distribution of blood flow in the isolated canine kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Specific stimulation and inhibition of renal prostaglandin release by angiotensin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The effects of angiotensin I and angiotensin II on the isolated tracheal muscle of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Stimulation of splenic prostaglandin release by angiotensin and specific inhibition by cysteine 8-AII

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin conversion in experimental renovascular hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of angiotensin converting enzyme inhibition on renal autoregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of angiotensin-converting enzyme inhibitor on response of plasma renin activity and aldosterone to tilting in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The role of the renin-angiotensin system in the initiation of renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Endocrine and Cardiovascular Consequences of Angiotensin Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The cost of scientific communication: the scientist as ad-man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of intrarenal angiotensin II blockade on renal function in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Regulation of aldosterone secretion by the renin-angiotensin system during sodium restriction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Failure of renin suppression by angiotensin II in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Converting enzyme inhibition with an orally active compound in hypertensive man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The effects of angiotensin II blockade in conscious sodium-depleted dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Adrenal Responses to Pharmacological Interruption of the Renin-Angiotensin System in Sodium-Restricted Normal Man*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of Angiotensin Converting Enzyme Inhibition on Blood Pressure, Plasma Renin Activity and Plasma Aldosterone in Essential Hypertension *

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin-Converting Enzyme Inhibitor (SQ 20881) in the Diagnosis of Renovascular Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Hemodialysis-Resistant Hypertension: Control with an Orally Active Inhibitor of Angiotensin-Converting Enzyme*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

(Des-Asp1) Angiotensin I: A Study of its Pressor and Steroidogenic Activities in Conscious Rats*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Increase in cyclic AMP levels and vasopressin release in response to angiotensin I in neurohypophyses: Blockade following inhibition of the converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of the renin-angiotensin-system in brattleboro rats with hereditary hypothalamic diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The role of angiotensin in the canine renal vascular response to barbiturate anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Contractile Responses to Angiotensin l and Angiotensin II in Hamster Uterine Smooth Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Vascular angiotensin receptors and their role in blood pressure control

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Contribution of intrarenal generation of prostaglandin to autoregulation of renal blood flow in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Action of Angiotensin I Converting Enzyme Inhibitor on the Control of Renal Function in the Cat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Rabbit tissue peptidases that hydrolyse the peptide hormone bradykinin. Differences in enzymic properties and concentration in rabbit tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Mechanism and modification of bradykinin-induced coronary vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The effects of kininase II inhibition by SQ 14225 on kidney kallikrein-kinin and prostaglandin systems in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Correlation of pulmonary structure with pharmacokinetic function

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Renal vascular response to interruption of the renin-angiotensin system in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The effect of angiotensin I converting enzyme inhibitor (SQ 20881) on the release of prostaglandins by rabbit kidney, in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Paradoxical inhibition of the effects of bradykinin by some sulfhydryl reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Potentiative effects of sulfhydryl compounds on carrageenin-induced oedema in rats and relationship to their potencies as inhibitors of angiostin-converting enzyme in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Drinking in water deprived rats after combined central angiotensin receptor and converting enzyme blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

The Inhibition of Angiotensin Converting Enzyme in Chronic Renal Hypertension by a Synthetic Peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Dose response of SQ 20,858 in chronic renal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of angiotensin conversion and prevention of renal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Converting enzyme inhibition and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effects of the Oral Converting Enzyme Inhibitor (SQ 14225) on One-Kidney Hypertension in the Dog

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Inhibition of Angiotensin-Converting Enzyme for Diagnosis of Renal-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Hemodynamic characteristics of hypertension after coronary bypass surgery and effects of the converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Converting Enzyme Inhibition in Hypertensive Emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of the synthetic peptide, Sq 20,881, on distribution of blood flow in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of the inhibition of angiotensin I converting enzyme in endotoxin and hemorrhagic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Quantitative analysis of the acute response to haemorrhage of the renin-angiotensin-vasoconstrictor feedback loop in areflexic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Effect of the inhibitor of angiotensin i converting enzyme on endocrine function and renal perfusion in haemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Converting Enzyme Inhibition Augments and Competitive Inhibition of Angiotensin II Partially Restores Reflex Adrenal Catecholamine Release in Anephric Dogs*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Modification by SQ 14225 of blood pressure and adrenal catecholamine response to hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Intestinal vasoconstriction following diuretic-induced volume depletion: role of angiotensin and vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

Improvement of chronic congestive heart-failure by oral captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970157-7

7 January 2021

10.1016/S0079-6468(08)70157-7

Identifiers

DOI

0 references

1 reference